Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Skin Laboratory PCLBKK:SKIN +3.53%20 Return-on-Tangible-Equity is -32.05% as of Mar. 2026. GuruFocus rates BKK:SKIN with a GF Score™ of 20/100. The stock has 2 warning signs investors should review. Among 1,885 Consumer Packaged Goods companies, Skin Laboratory PCL ranks worse than 87.21% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Skin Laboratory PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿-31.1 Mil. Skin Laboratory PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿97.0 Mil. Therefore, Skin Laboratory PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was -32.05%.
The historical rank and industry rank for Skin Laboratory PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:SKIN'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -11.14 Med: 15.48 Max: 23.28
Current: -11.14
During the past 4 years, Skin Laboratory PCL's highest Return-on-Tangible-Equity was 23.28%. The lowest was -11.14%. And the median was 15.48%.
BKK:SKIN's Return-on-Tangible-Equity is ranked worse than 87.21% of 1885
companies
in the Consumer Packaged Goods industry
Industry Median: 8.04
vs BKK:SKIN: -11.14
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Skin Laboratory PCL Return-on-Tangible-Equity Related Terms
Skin Laboratory PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Skin Laboratory PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:SKIN vs PG, CL, KVUE: Return-on-Tangible-Equity Comparison
For the Household & Personal Products subindustry, Skin Laboratory PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Skin Laboratory PCL Return-on-Tangible-Equity vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Skin Laboratory PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Skin Laboratory PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of -32.05% mean?
Skin Laboratory PCL (BKK:SKIN) has a Return-on-Tangible-Equity of -32.05% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Skin Laboratory PCL and its competitors. According to the industry distribution chart, Skin Laboratory PCL ranks #1644 out of 1885 companies in the Consumer Packaged Goods industry, placing it in the top 87.2%.
Is Skin Laboratory PCL's Return-on-Tangible-Equity too high?
Skin Laboratory PCL's current Return-on-Tangible-Equity is -32.05%. Based on the distribution chart, Skin Laboratory PCL ranks #1644 out of 1885 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Skin Laboratory PCL has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Skin Laboratory PCL's Return-on-Tangible-Equity compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Skin Laboratory PCL ranks #1644 out of 1885 companies for Return-on-Tangible-Equity. This places Skin Laboratory PCL in the lower half of its industry. The industry median Return-on-Tangible-Equity is 8.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Consumer Packaged Goods company?
The median Return-on-Tangible-Equity among Consumer Packaged Goods companies is 8.04, based on 1,885 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Skin Laboratory PCL and its competitors. For the Consumer Packaged Goods industry, the median Return-on-Tangible-Equity is 8.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Skin Laboratory PCL's current Return-on-Tangible-Equity is -32.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Laboratory PCL stock overvalued right now?
Skin Laboratory PCL (BKK:SKIN) has a current Return-on-Tangible-Equity of -32.05%. The current Return-on-Tangible-Equity is -32.05%. Skin Laboratory PCL's overall GF Score™ is 20/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Skin Laboratory PCL (BKK:SKIN), the current Return-on-Tangible-Equity is -32.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Skin Laboratory PCL is engaged in the business of inventing, developing, contracting production, and distributing beauty products under the Company's various brands, including facial serum products, sunscreen products, facial cleansers, facial care products, and other products. The Company's core business is only one operating segment, which is manufacturing and distributing skin creams, beauty creams, cosmetics, and operates virtually its business in one geographical location in Thailand.
20GF Score
Get the complete analysis for BKK:SKIN
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:SKIN has been successfully added to your 
